Clinical trial
A Multicenter, Retrospective, Post-Market Clinical Follow-Up Study to Evaluate the Performance and Safety of Suturable DuraGen™
NCT04923867 is registered in ClinicalTrials.gov with Integra LifeSciences Corporation as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multicenter, Retrospective, Post-Market Clinical Follow-Up Study to Evaluate the Performance and Safety of Suturable DuraGen™
- Lead sponsor
- Integra LifeSciences Corporation
- Phase
- Observational
- Overall status
- Completed
- Start date
- April 28, 2021
- Completion date
- July 31, 2024
- Enrollment
- 106 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.